BerGenBio's Series C Round

BerGenBio raised a round of funding on March 18, 2016.

BerGenBio is an oncology-based biopharmaceutical company focused on pursuing therapeutic treatments for cancer and supporting the screening and identification of a wide array of potential targets in c…

Articles about BerGenBio's Series C Round: